Some people are getting a bit cranky about the fact that I pissed in their cornflakes this morning, so here's a little more exposition.
A charismatic new face appeared on the political scene, somebody who was honest and sympathetic and intelligent. So he was a little more religious than I liked; he's still a good man who promises to repair the damage of the former presidency. He's running against a relic of that previous corrupt administration, his campaign slogan is all about change, and I am so relieved to have a promising choice. I campaigned for him, I stayed up all night with my friends on election night cheering him on, and I woke up the next morning optimistic for the future, glad that we finally had a progressive president.
Obviously, that wasn't this year's election. It was 1976, the very first presidential election in which I was eligible to vote, and the candidate was Jimmy Carter, a man I still think was probably the most honorable and decent president of the 20th century. But optimism and good intentions were not, are not enough. What followed Carter's election was well-meaning bumbling, a dismal and unaccomplished presidency, and Ronald Reagan, the catastrophe that paved the road to our current state.
This election was so much like that one, only even more so. And I dread the possibility that jubilation will lead to complacency, that moderation will produce stasis, and that what will follow an Obama presidency could be something far, far worse than we can imagine.
So no, no ebullience from me, no brief relaxation into celebration. I'm charging up my cattle prod, because I want to goose the Obama administration into actually getting something done in the coming years. I think Obama could be a great president, especially since greatness in that office is measured by the magnitude of the challenges faced (which are off the scale), and the ability of the leader to rise to them. There is reason to have hope, but hope doesn't get the job done.
Ten years from now I don't want to be praising Obama by commenting on his generosity and his carpentry skills.
Read the comments on this post...
Add to del.icio.us
Digg this
Post to Furl
Add to reddit
Add to myYahoo!I’m still plugging away at the book, and I have a few talks and interviews still on the schedule:Wednesday, November 5 (tonight): I’ll be toasting the elections at the Boulder Drinking Skeptically meetup. That’s at 6:00 p.m. at Old[...]
Read The Full Article:
http://blogs.discovermagazine.com/badastronomy/2008/11/05/more-interviews-and-suc
h/
Add to del.icio.us
Digg this
Post to Furl
Add to reddit
Add to myYahoo!Proactive measures can reduce hip fracture rates by an average of 37.2 percent — and as much as 50 percent — among those at risk, according to a study conducted by Kaiser Permanente Southern California. The study was published[...]
Read The Full Article:
http://feeds.feedburner.com/~r/zampbioworld/iblI/~3/443519506/10345
Add to del.icio.us
Digg this
Post to Furl
Add to reddit
Add to myYahoo!Debiopharm Group (Debiopharm), a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, announced that Debiovision Inc., its Canadian affiliate, filed its Complete Response to the approvable[...]
Read The Full Article:
http://feeds.feedburner.com/~r/zampbioworld/iblI/~3/443519508/10344
Add to del.icio.us
Digg this
Post to Furl
Add to reddit
Add to myYahoo!Oncolytics Biotech Inc. (”Oncolytics”) (TSX:ONC, NASDAQ:ONCY) announced that it has made a decision to pursue a pivotal (Phase II/III) randomized trial using the combination of REOLYSIN(R) with paclitaxel/carboplatin in refractory [...]
Read The Full Article:
http://feeds.feedburner.com/~r/zampbioworld/iblI/~3/443519510/10343
Add to del.icio.us
Digg this
Post to Furl
Add to reddit
Add to myYahoo!NicOx S.A. (Euronext Paris: COX) announced positive top-line results from a 118 patient Ambulatory Blood Pressure Monitoring (ABPM) trial (the 111 study), which compared the 24-hour blood pressure profile of escalating doses of naproxcinod and[...]
Read The Full Article:
http://feeds.feedburner.com/~r/zampbioworld/iblI/~3/443492014/10342
Add to del.icio.us
Digg this
Post to Furl
Add to reddit
Add to myYahoo!Cepheid (Nasdaq: CPHD) announced the U.S. Food & Drug Administration (FDA) categorized Cepheid’s Xpert(TM) MRSA/SA Blood Culture (BC) test as “Moderate Complexity” under the Clinical Laboratory Improvement[...]
Read The Full Article:
http://feeds.feedburner.com/~r/zampbioworld/iblI/~3/443492019/10341
Add to del.icio.us
Digg this
Post to Furl
Add to reddit
Add to myYahoo!Children born with a condition that can prevent them from growing to a normal height now have a new treatment option available with the approval of Norditropin(R) (somatropin [rDNA origin] injection) for the treatment of short stature in children[...]
Read The Full Article:
http://feeds.feedburner.com/~r/zampbioworld/iblI/~3/443492021/10340
Add to del.icio.us
Digg this
Post to Furl
Add to reddit
Add to myYahoo!Researchers in Sweden suggest in a forthcoming issue in the journal IJRAM that double standards in health and safety regulations for occupational hazards and for the public should be removed so that employees are afforded the same rights as[...]
Read The Full Article:
http://feeds.feedburner.com/~r/zampbioworld/iblI/~3/443492024/10339
Add to del.icio.us
Digg this
Post to Furl
Add to reddit
Add to myYahoo!Doctors use diagnostic sonography or ultrasound to visualise organs and other internal structures of the human body. Dutch researcher Koos Huijssen has developed a computer model that can predict the sound transmission of improved designs for ultrasound[...]
Read The Full Article:
http://feeds.feedburner.com/~r/zampbioworld/iblI/~3/443492025/10338
Add to del.icio.us
Digg this
Post to Furl
Add to reddit
Add to myYahoo!
Powered by blogdig.net